Cardiac autonomic dysfunction in hemodialysis patients assessed by heart rate variability

Area of Science:

• Nephrology
• Cardiology
• Autonomic Neuroscience

Background:

• Sudden cardiac death (SCD) is a major concern for patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD).
• Autonomic dysfunction, affecting over 50% of ESRD patients, is a recognized risk factor for SCD.
• Cardiac autonomic dysfunction is linked to ventricular arrhythmias, a common precursor to SCD.

Purpose of the Study:

• To review the role of heart rate variability (HRV) in assessing cardiac autonomic function in HD patients.
• To explore the association between impaired HRV and the elevated risk of SCD in ESRD patients.
• To discuss intervention studies utilizing HRV as a surrogate marker in HD patients.

Main Methods:

• Focus on heart rate variability (HRV) as a non-invasive measure of cardiac autonomic function.
• Review of existing literature on HRV in end-stage renal disease (ESRD) and hemodialysis (HD) patients.
• Analysis of intervention studies employing HRV in the HD population.

Main Results:

• End-stage renal disease (ESRD) patients on hemodialysis (HD) exhibit impaired heart rate variability (HRV).
• This impairment in HRV is a potential contributing factor to the high incidence of sudden cardiac death (SCD) in this cohort.
• Intervention studies have explored HRV as a surrogate parameter in HD patients.

Conclusions:

• Impaired HRV is a significant finding in end-stage renal disease (ESRD) patients on hemodialysis (HD).
• HRV assessment offers a valuable non-invasive method for evaluating cardiac autonomic function in HD patients.
• Further research and interventions targeting HRV may help mitigate the risk of sudden cardiac death (SCD) in ESRD patients.